Product Name | MF | CAS | Details |
---|
Rucaparib | C19H18FN3O | 283173-50-2 | Details |
PD 169316 | C20H13FN4O2 | 152121-53-4 | Details |
Rimonabant hydrochloride | C22H21Cl3N4O.ClH | 158681-13-1 | Details |
(2R)-3-Cyclopentyl-2-[4-(methanesulfonyl)phenyl]-N-(thiazol-2-yl)propionamide | C18H22N2O3S2 | 300353-13-3 | Details |
PF-01367338 | C19H21FN3O5P | 459868-92-9 | Details |
N-[(1R)-5-(1,1-Dimethylethyl)-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-ylurea | C21H24N4O | 808756-71-0 | Details |
ALX 5407 HYDROCHLORIDE | C24H24FNO3 | 571147-18-7 | Details |
PD 166793 | C17H18BrNO4S | 199850-67-4 | Details |
MK-677 | C28H40N4O8S2 | 159752-10-0 | Details |
1,3-dipropyl-8-(3-noradamantyl)xanthine | C20H28N4O2 | 136199-02-5 | Details |
AM 630 | C23H25IN2O3 | 164178-33-0 | Details |
Benzofuro[3,2-d]pyriMidin-4(3H)-one, 8-chloro-2-(2S)-2-pyrrolidinyl- | C14H12ClN3O2 | 1169558-38-6 | Details |
rel-N-Methyl-N-[[(1R,2S)-1,2,3,4-tetrahydro-6-methoxy-1-phenyl-2-naphthalenyl]methyl]glycine hydrochloride | C21H26ClNO3 | 949588-40-3 | Details |
(S)-2-Amino-5-methoxytetralin Hydrochloride | C11H15NO.HCl | 58349-17-0 | Details |
SILYBIN (A and B)(P) | C25H22O10 | 142797-34-0 | Details |
LY2886721 | C18H16F2N4O2S | 1262036-50-9 | Details |
7-[[4-(2,6-Dichlorophenyl)-1-piperidinyl]methyl]-6,7,8,9-tetrahydro-1-methyl-5H-benzocyclohepten-5-olhydrochloride | C24H29Cl2NO | 371980-98-2 | Details |
U0126-EtOH | C20H22N6OS2 | 1173097-76-1 | Details |
ONO-8711 | C22H30ClNO4S | 216158-34-8 | Details |
IMETIT DIHYDROBROMIDE | C6H12Br2N4S | 32385-58-3 | Details |
DIMAPRIT DIHYDROCHLORIDE | C6H16ClN3S | 23256-33-9 | Details |
apratastat | C17H22N2O6S2 | 287405-51-0 | Details |
N-[trans-4-[2-(6-Cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl]-4-quinolinecarboxamide | C28H30N4O | 215803-78-4 | Details |
BenzenesulfonaMide, 5-(phenylsulfonyl)-N-4-piperidinyl-2-(trifluoroMethyl)- | C18H19F3N2O4S2 | 915759-45-4 | Details |
LH-846 | C16H13ClN2OS | 639052-78-1 | Details |
FGFR inhibitor | C18H15N2NaO4 | 848318-25-2 | Details |
ZLN005 | C17H18N2 | 49671-76-3 | Details |
N-[2-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]ETHYL]-N-2-PYRIDINYL-CYCLOHEXANECARBOXAMIDE MALEATE | C29H38N4O6 | 634908-75-1 | Details |
5'-D(ATGAAAATCAGGGTTAGG)-3', SODIUM SALT | C19H17Cl3N4O3 | 1047953-91-2 | Details |
α,α,-Dimethyl-4-[2-methyl-8-[2-(3-pyridinyl)ethynyl]-1H-imidazo[4,5-c]quinolin-1-yl]-benzeneacetonitrile | C28H21N5 | 853910-02-8 | Details |
b-AP15 | C22H17N3O6 | 1009817-63-3 | Details |
STF-118804 | C25H23N3O4S | 894187-61-2 | Details |
ReModelin | C15H14N4S | 949912-58-7 | Details |
ZONIPORIDE | C17H16N6O | 241800-98-6 | Details |
N-Methyl-4-[7-(4-cyano-3-trifluoromethylphenyl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl]-2-fluorobenzamide | C22H16F4N4O2S | 915087-27-3 | Details |
NSC 55712 | C8H14Cl2N4S3 | 2076-91-7 | Details |
SR 48692 | C32H31ClN4O5 | 146362-70-1 | Details |
α,α-Diphenyl-4-[(3-pyridinylmethylene)amino]-1-piperazinepentanenitrile | C27H29N5 | 218136-59-5 | Details |
(2RS)-2-(Cyclohex-1-enyl)-2-(4-Methoxyphenyl)-N,N-diMethylethanaMine Hydrochloride | C17H26ClNO | 93413-79-7 | Details |
Deltarasin (hydrochloride) | C40H40Cl3N5O | 1440898-82-7 | Details |
SF1670(PTENinhibitor) | C19H17NO3 | 345630-40-2 | Details |
Pipofezine | C16H19N5O | 24886-52-0 | Details |
N-(4-[4-(2-METHOXYPHENYL)-PIPERAZIN-1-YL]-BUTYL-5-(DIMETHYLAMINO)-NAPTHALENE-1-SULFONAMIDE MALEATE | C31H40N4O7S | 390803-40-4 | Details |
MPEP HYDROCHLORIDE | C14H11N.ClH | 219911-35-0 | Details |
AT 7519 mesylate | C17H21Cl2N5O5S | 902135-89-1 | Details |
((R)-5-METHOXY-1,2,3,4-TETRAHYDRO-NAPHTHALEN-2-YL)-PROPYL-AMINE HYDROCHLORIDE | C14H21NO | 101403-25-2 | Details |
VX-661 | C26H27F3N2O6 | 1152311-62-0 | Details |
4-[2-[2-[(2R)-2-Methyl-1-pyrrolidinyl]ethyl]-5-benzofuranyl]benzonitrile tartrate | C26H28N2O7 | 460748-71-4 | Details |
(S)-3-(4-((4'-(Trifluoromethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)hex-4-ynoic acid | C26H21F3O3 | 865231-46-5 | Details |
PD 123,319 DITRIFLUOROACETATE | C31H32N4O3 | 130663-39-7 | Details |
1-(2-DIPHENYLMETHOXYETHYL)-4-(3-PHENYL-2-PROPENYL)-PIPERAZINE DIHYDROCHLORIDE | C28H32N2O | 67469-57-2 | Details |
Vonoprazan FuMarate | C21H20FN3O6S | 881681-01-2 | Details |
(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE | C16H21NO3 | 85416-73-5 | Details |
(AR,BS)-ALPHA-(4-HYDROXYPHENYL)-BETA-METHYL-4-(PHENYLMETHYL)-1-PIPERIDINEPROPANOL MALEATE | C22H29NO2 | 169274-78-6 | Details |
N-(2-Chlorophenyl)-4-(2-(4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenylamino)-5-fluoropyrimidin-4-ylamino)benzamide | C31H31ClFN7O2 | 1158838-45-9 | Details |
TAK-063 | C23H17FN6O2 | 1238697-26-1 | Details |
HYDROXY MIFEPRISTONE | C29H35NO3 | 105012-15-5 | Details |
5-((7-(BENZYLOXY)QUINAZOLIN-4-YL)AMINO)-4-FLUORO-2-METHYLPHENOL | C22H18FN3O2 | 193001-14-8 | Details |
GSK J1 | C22H23N5O2 | 1373422-53-7 | Details |
ML234 | C21H23N3O2 | 1222800-79-4 | Details |
6-NITRO-1H-1LAMBDA6-BENZO[B]THIOPHENE-1,1-DIONE | C8H5NO4S | 19983-44-9 | Details |
JNK-IN-8 | C29H29N7O2 | 1410880-22-6 | Details |
L 2-401 | C16H13FN2O2S | 883050-24-6 | Details |
AICAR (phosphate) | C9H17N4O9P | 681006-28-0 | Details |
3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione | C25H22N6O2 | 425637-18-9 | Details |
3-Amino-N-(4-methoxybenzyl)-4,6-dimethylthieno[2,3-b]pyridinecarboxamide | C18H19N3O2S | 409351-28-6 | Details |
IWP L6 | C25H20N4O2S2 | 1427782-89-5 | Details |
4'-ACETYL-N-[4-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]BUTYL]-[1,1'-BIPHENYL]-4-CARBOXAMIDE | C30H35N3O3 | 162408-66-4 | Details |
1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE | C8H10N2OS | 284028-90-6 | Details |
6-pentadecylsalicylic acid | C22H36O3 | 16611-84-0 | Details |
TH588 | C13H12Cl2N4 | 1609960-31-7 | Details |
(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol | C32H31F2N3O2 | 167354-41-8 | Details |
2-PHENYLTHIO-5-PROPIONYL PHENYL ACETIC ACID | C14H21N | 92321-29-4 | Details |
rac-Rotigotine Hydrochloride | C19H26ClNOS | 102120-99-0 | Details |
4-[N-(4-Carboxybutyl)-N-[2-[2-[4-(2-phenylethyl)benzyloxy]phenyl]ethyl]aMinoMethyl]benzoic acid | C36H39NO5 | 329773-35-5 | Details |
Piboserod Hydrochloride | C22H32ClN3O2 | 178273-87-5 | Details |
PF-543 (Citrate) | C33H39NO11S | 1415562-83-2 | Details |
Nrf1-activator-1 | C33H44F2N2O3 | 1474034-05-3 | Details |
Nalmefene | C21H25NO3 | 55096-26-9 | Details |
2H-PYRAZINO[1,2-A]PYRIMIDINE-1(6H)-CARBOXAMIDE,HEXAHYDRO-6-[(4-HYDROXYPHENYL)METHYL]-8-(1-NAPHTHALENYLMETHYL)-4,7-DIOXO-N-(PHENYLMETHYL)-,(6R,9AR)-REL- | C33H32N4O4 | 780757-88-2 | Details |
LB 42708 | C30H27BrN4O2 | 226929-39-1 | Details |
Shz-1 | C13H11BrN2O3S | 326886-05-9 | Details |
7-Methoxycoumarin | C11H15NO | 4003-89-8 | Details |
JNJ-26481585 | C21H26N6O2 | 875320-29-9 | Details |
N-[4-METHOXY-3-(4-METHYLPIPERAZIN-1-YL)-PHENYL]-4-[2-METHYL-4-(5-METHYL-1,2,4-OXADIAZOL-3-YL)PHENYL]BENZAMIDE | C29H31N5O3 | 148672-13-3 | Details |
4-(3-(2H-1,2,3-Triazo-2-yl)phenylaMino)-2-((1R,2S)-2-aMinocyclohexylaMino) pyriMidine-5-carboxaMide | C19H23N9O | 1370261-96-3 | Details |
Optovin | C15H13N3OS2 | 348575-88-2 | Details |
FPH2 | C14H16ClN5O2S | 957485-64-2 | Details |
1-[4-Amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethanone | C18H19FN4O2 | 821794-92-7 | Details |
AEG 3482 | C10H8N4O2S2 | 63735-71-7 | Details |
D-106669 | C17H18N6O | 938444-93-0 | Details |
NVP BGJ398 phosphate | C26H34Cl2N7O7P | 1310746-10-1 | Details |
Nexturastat A | C19H23N3O3 | 1403783-31-2 | Details |
3,4-dimethoxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]benzenesulfonamide | C17H15N3O6S2 | 199666-03-0 | Details |
N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[(5-(trifluoromethyl)pyridin-2-yl)oxy]propanamide( MK 0364) | C27H25ClF3N3O2 | 701977-09-5 | Details |
Ziprasidone | C21H21ClN4OS | 122883-93-6 | Details |
U-73122 | C29H40N2O3 | 112648-68-7 | Details |
BAM7 | C21H19N5O2S | 331244-89-4 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 |